Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announced the U.S. Food and Drug Administration (FDA) has...
Werfen, announced 510(k) clearance of Aptiva Connective Tissue Disease (CTD) Essential reagent by the US Food and Drug Administration (FDA).
The Aptiva CTD Essential complements...
Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, announced that the U.S. Food and Drug Administration (FDA) has...
ANeuroTech, a leader in the development of innovative mental health treatments with minimal or no side effects, announces that following a successful pre-IND meeting,...
Cellmyx, the authority on autologous adipose grafting and transfer, and a leader in medical technologies for orthopedic physicians, pain management and regenerative medicine, announces...
